{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:39Z","timestamp":1789053159995,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04817-2","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:37:16Z","timestamp":1780483036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Selenoprotein P deficiency in MASLD: association with insulin resistance and liver fibrosis: a prospective case-control study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2030-0856","authenticated-orcid":false,"given":"Mona A","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar Saad","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman H","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdelghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Abd","family":"el Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ahmed Elsayed","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ashoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"Suppl","key":"4817_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"Z -Younossi","year":"2025","unstructured":"Younossi Z, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350. https:\/\/doi.org\/10.3350\/cmh.2024.0431.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"4817_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","volume":"44","author":"Z -Younossi","year":"2024","unstructured":"Younossi Z, Golabi P, Paik J, Owrangi S, Y\u0131lmaz Y, El-Kassas M, et al. Prevalence of metabolic dysfunction\u2010associated steatotic liver disease in the middle east and north africa. Liver Int. 2024;44(4):1061\u201370. https:\/\/doi.org\/10.1111\/liv.15852.","journal-title":"Liver Int"},{"key":"4817_CR3","doi-asserted-by":"publisher","unstructured":"Cusi K, Abdelmalek M, Apovian C, Balapattabi K, Bannuru R, Barb D et al. Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. a consensus report of the american diabetes association. Diabetes Care 2025. https:\/\/doi.org\/10.2337\/dci24-0094.","DOI":"10.2337\/dci24-0094"},{"issue":"2","key":"4817_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/jcm14020428","volume":"14","author":"E -Michalopoulou","year":"2025","unstructured":"Michalopoulou E, Thymis J, Lampsas S, Pavlidis G, Katogiannis \u039a, Vlachomitros D, et al. The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment. J Clin Med. 2025;14(2):428. https:\/\/doi.org\/10.3390\/jcm14020428.","journal-title":"J Clin Med"},{"key":"4817_CR5","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.molmet.2020.101143","volume":"50","author":"K -Bence","year":"2021","unstructured":"Bence K, Birnbaum M. Metabolic drivers of non-alcoholic fatty liver disease. Mol Metabolism. 2021;50:101143. https:\/\/doi.org\/10.1016\/j.molmet.2020.101143.","journal-title":"Mol Metabolism"},{"key":"4817_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P -Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389\u201397. e310.","journal-title":"Gastroenterology"},{"key":"4817_CR7","doi-asserted-by":"publisher","first-page":"175628482412763","DOI":"10.1177\/17562848241276334","volume":"17","author":"D -Hudson","year":"2024","unstructured":"Hudson D, Afzaal T, Bualbanat H, AlRamdan R, Howarth N, Parthasarathy P, et al. Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. Ther Adv Gastroenterol. 2024;17:17562848241276334. https:\/\/doi.org\/10.1177\/17562848241276334.","journal-title":"Ther Adv Gastroenterol"},{"key":"4817_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejim.2024.01.013","volume":"122","author":"M -Zoncap\u00e8","year":"2024","unstructured":"Zoncap\u00e8 M, Liguori A, Tsochatzis EA. Non-invasive testing and risk-stratification in patients with MASLD. Eur J Intern Med. 2024;122:11\u20139. https:\/\/doi.org\/10.1016\/j.ejim.2024.01.013.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"4817_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/molecules30030437","volume":"30","author":"-NoneS Wang","year":"2025","unstructured":"Wang -NoneS, Wu Y, Chen Y, Wu T, Yuan X. Selenium and Selenoproteins: Mechanisms, Health Functions, and Emerging Applications. Molecules. 2025;30(3):437\u20137.","journal-title":"Molecules"},{"issue":"7","key":"4817_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/antiox11071263","volume":"11","author":"R -Yu","year":"2022","unstructured":"Yu R, Wang Z, Ma M, Xu P, Liu L, Tinkov A, et al. Associations between circulating selenop level and disorders of glucose and lipid metabolism: a meta-analysis. Antioxidants. 2022;11(7):1263. https:\/\/doi.org\/10.3390\/antiox11071263.","journal-title":"Antioxidants"},{"key":"4817_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2018.05.066","volume":"127","author":"S -Short","year":"2018","unstructured":"Short S, Pilat J, Williams C. Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease. Free Radic Biol Med. 2018;127:26\u201335. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.05.066.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"4817_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/diagnostics8040070","volume":"8","author":"L -Santos","year":"2018","unstructured":"Santos L, Neves C, Melo M, Soares P. Selenium and Selenoproteins in Immune Mediated Thyroid Disorders. Diagnostics. 2018;8(4):70. https:\/\/doi.org\/10.3390\/diagnostics8040070.","journal-title":"Diagnostics"},{"issue":"7","key":"4817_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/nu11071457","volume":"11","author":"S -Ibrahim","year":"2019","unstructured":"Ibrahim S, Kerkadi A, Agouni A. Selenium and Health: An Update on the Situation in the Middle East and North Africa. Nutrients. 2019;11(7):1457. https:\/\/doi.org\/10.3390\/nu11071457.","journal-title":"Nutrients"},{"issue":"10","key":"4817_CR14","doi-asserted-by":"publisher","first-page":"e1590","DOI":"10.1016\/s2214-109x(24)00276-6","volume":"12","author":"S Passarelli","year":"2024","unstructured":"Passarelli S, Free C, Shepon A, Beal T, Batis C, Golden C. Global estimation of dietary micronutrient inadequacies: a modelling analysis. Lancet Global Health. 2024;12(10):e1590\u20139. https:\/\/doi.org\/10.1016\/s2214-109x(24)00276-6.","journal-title":"Lancet Global Health"},{"issue":"3","key":"4817_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1248\/bpb.b19-00837","volume":"43","author":"R -Tsutsumi","year":"2020","unstructured":"Tsutsumi R, Saito Y. Selenoprotein p; p for plasma, prognosis, prophylaxis, and more. Biol Pharm Bull. 2020;43(3):366\u201374. https:\/\/doi.org\/10.1248\/bpb.b19-00837.","journal-title":"Biol Pharm Bull"},{"issue":"41","key":"4817_CR16","doi-asserted-by":"publisher","first-page":"66679","DOI":"10.18632\/oncotarget.11439","volume":"7","author":"X -Hu","year":"2016","unstructured":"Hu X, Du S, Yu J, Yang X, Yang C, Zhou D, et al. Common housekeeping proteins are upregulated in colorectal adenocarcinoma and hepatocellular carcinoma, making the total protein a better housekeeper. Oncotarget. 2016;7(41):66679\u201388. https:\/\/doi.org\/10.18632\/oncotarget.11439.","journal-title":"Oncotarget"},{"key":"4817_CR17","doi-asserted-by":"publisher","unstructured":"Huang K, Chen D, Yu L, Wu Z, Chen Q, Wang X, et al. Serum secreted phosphoprotein 1 level is associated with plaque vulnerability in patients with coronary artery disease. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1285813.","DOI":"10.3389\/fimmu.2024.1285813"},{"issue":"8","key":"4817_CR18","doi-asserted-by":"publisher","first-page":"E1325","DOI":"10.1210\/jc.2011-0620","volume":"96","author":"S -Yang","year":"2011","unstructured":"Yang S, Hwang S, Choi H, Yoo H, Seo J, Kim S, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab. 2011;96(8):E1325\u20139. https:\/\/doi.org\/10.1210\/jc.2011-0620.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4817_CR19","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1002\/jcp.30121","volume":"236","author":"Y -Chen","year":"2020","unstructured":"Chen Y, He X, Chen X, Li Y, Ke Y. Sep is elevated in nafld and participates in nafld pathogenesis through ampk\/acc pathway. J Cell Physiol. 2020;236(5):3800\u20137. https:\/\/doi.org\/10.1002\/jcp.30121.","journal-title":"J Cell Physiol"},{"issue":"9","key":"4817_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1055\/a-0811-9136","volume":"127","author":"S -P\u03bflyzos","year":"2019","unstructured":"P\u03bflyzos S, Kountouras J, Mavrouli M, Katsinelos P, Doulberis M, Gavana E, et al. Selenoprotein p in patients with nonalcoholic fatty liver disease. Exp Clin Endocrinol Diabetes. 2019;127(9):598\u2013602. https:\/\/doi.org\/10.1055\/a-0811-9136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"4817_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"M -Rinella","year":"2023","unstructured":"Rinella M, Lazarus J, Ratziu V, Francque S, Sanyal A, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"3","key":"4817_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F -Tacke","year":"2024","unstructured":"Tacke F, Horn P, Wong V, Ratziu V, Bugianesi E, Francque S, et al. EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","journal-title":"J Hepatol"},{"key":"4817_CR23","unstructured":"Immundiagnostik AG, Selenoprotein P, SEPP1. () ELISA. Bensheim (Germany): Immundiagnostik AG. Available from: https:\/\/www.immundiagnostik.com\/en\/portfolio\/testkits\/yc5900. Cited 2025 Jul 14."},{"issue":"2","key":"4817_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7123\/01.ejim.0000419544.37462.5f","volume":"24","author":"M -Hegazy","year":"2012","unstructured":"Hegazy M, Mostafa A. Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients. Egypt J Intern Med. 2012;24(2):27\u201331. https:\/\/doi.org\/10.7123\/01.ejim.0000419544.37462.5f.","journal-title":"Egypt J Intern Med"},{"issue":"9","key":"4817_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"D -Huang","year":"2020","unstructured":"Huang D, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J. 2020;50(9):1038\u201347. https:\/\/doi.org\/10.1111\/imj.14709.","journal-title":"Intern Med J"},{"issue":"3","key":"4817_CR26","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/ijms19030878","volume":"19","author":"H -Chadani","year":"2018","unstructured":"Chadani H, Usui S, Inoue O, Kusayama T, Takashima S, Kato T, et al. Endogenous selenoprotein P, a liver-derived secretory protein, mediates myocardial ischemia\/reperfusion injury in mice. Int J Mol Sci. 2018;19(3):878. https:\/\/doi.org\/10.3390\/ijms19030878.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4817_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.clinre.2017.01.005","volume":"41","author":"I -Cetinda\u011fl\u0131","year":"2017","unstructured":"Cetinda\u011fl\u0131 I, Kara M, Tano\u011flu A, \u00d6zalper V, Ar\u0131bal S, Han\u00e7erli Y, et al. Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Res Hepatol Gastroenterol. 2017;41(5):516\u201324. https:\/\/doi.org\/10.1016\/j.clinre.2017.01.005.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"4817_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.32734\/jetromi.v6i1.14771","volume":"6","author":"D -Villarsi","year":"2024","unstructured":"Villarsi D, Sungkar T. Association between body mass index (BMI) and the incidence of non-alcoholic fatty liver disease (NAFLD). J Endocrinol Trop Med Infect Dis (JETROMI). 2024;6(1):7\u201312.","journal-title":"J Endocrinol Trop Med Infect Dis (JETROMI)"},{"issue":"5","key":"4817_CR29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","volume":"64","author":"C -Pirola","year":"2015","unstructured":"Pirola C, Gianotti T, Casta\u00f1o G, Mallardi P, Martino J, Ledesma M, et al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut. 2015;64(5):800\u201312. https:\/\/doi.org\/10.1136\/gutjnl-2014-306996.","journal-title":"Gut"},{"issue":"6","key":"4817_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L -Li","year":"2016","unstructured":"Li L, Liu D, Yan H, Wang Z, Zhao S, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta\u2010analysis of 21 cohort studies. Obes Rev. 2016;17(6):510\u20139. https:\/\/doi.org\/10.1111\/obr.12407.","journal-title":"Obes Rev"},{"issue":"1","key":"4817_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4093\/dmj.2013.37.1.63","volume":"37","author":"H -Choi","year":"2013","unstructured":"Choi H, Hwang S, Lee C, Hong H, Yang S, Yoo H, et al. Increased selenoprotein P levels in subjects with visceral obesity and nonalcoholic fatty liver disease. Diabetes Metab J. 2013;37(1):63. https:\/\/doi.org\/10.4093\/dmj.2013.37.1.63.","journal-title":"Diabetes Metab J"},{"key":"4817_CR32","doi-asserted-by":"publisher","unstructured":"Jiang Y, Wu L, Zhu X, Bian H, Gao X, Xia M. Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics. Lipids Health Dis. 2024;23(1). https:\/\/doi.org\/10.1186\/s12944-024-02092-2.","DOI":"10.1186\/s12944-024-02092-2"},{"issue":"9","key":"4817_CR33","doi-asserted-by":"publisher","first-page":"e105610","DOI":"10.1371\/journal.pone.0105610","volume":"9","author":"G -Tarantino","year":"2014","unstructured":"Tarantino G, Costantini S, Finelli C, Capone F, Guerriero E, Sala N, et al. Carotid Intima-Media Thickness Is Predicted by Combined Eotaxin Levels and Severity of Hepatic Steatosis at Ultrasonography in Obese Patients with Nonalcoholic Fatty Liver Disease. PLoS ONE. 2014;9(9):e105610. https:\/\/doi.org\/10.1371\/journal.pone.0105610.","journal-title":"PLoS ONE"},{"issue":"16","key":"4817_CR34","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1038\/s44319-025-00516-3","volume":"26","author":"D -Hoang","year":"2025","unstructured":"Hoang D, Bouvi\u00e8re J, Galvis J, Moull\u00e9 P, Mercier O, Migliavacca E, et al. Immune aging impairs muscle regeneration via macrophage-derived anti-oxidant selenoprotein P. EMBO Rep. 2025;26(16):4153\u201379. https:\/\/doi.org\/10.1038\/s44319-025-00516-3.","journal-title":"EMBO Rep"},{"issue":"4","key":"4817_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3350\/cmh.2024.0471","volume":"30","author":"Y -Zheng","year":"2024","unstructured":"Zheng Y, Xiong Z, Zhao L, Huang C, Yong Q, Fang D, et al. The role of SPP1 in MASLD pathogenesis: Therapeutic insights into ursolic acid\u2019s mechanisms of action: Correspondence to editorial on Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2024;30(4):1019\u201322. https:\/\/doi.org\/10.3350\/cmh.2024.0471.","journal-title":"Clin Mol Hepatol"},{"key":"4817_CR36","doi-asserted-by":"publisher","unstructured":"Wu X, Yuan C, Pan J, Zhou Y, Pan X, Kang J, et al. CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis. Sci Rep. 2024;14(1). https:\/\/doi.org\/10.1038\/s41598-024-66287-4.","DOI":"10.1038\/s41598-024-66287-4"},{"key":"4817_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/DMSO.S229590","volume":"13","author":"M -Hegazy","year":"2020","unstructured":"Hegazy M, Saleh SA, Ezzat A, Behiry ME. Novel application of the traditional lipid ratios as strong risk predictors of NASH. Diabetes Metab Syndr Obes. 2020;13:297\u2013305. https:\/\/doi.org\/10.2147\/DMSO.S229590.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4817_CR38","doi-asserted-by":"publisher","unstructured":"Xie Y, Kong W, Wang X, Wu Z. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes. BMC Endocr Disord. 2022;22(1). https:\/\/doi.org\/10.1186\/s12902-022-01134-z.","DOI":"10.1186\/s12902-022-01134-z"},{"issue":"11","key":"4817_CR39","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1038\/ajg.2010.275","volume":"105","author":"J -Bae","year":"2010","unstructured":"Bae J, Cho Y, Lee W, Seo H, Rhee E, Park S, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol. 2010;105(11):2389\u201395. https:\/\/doi.org\/10.1038\/ajg.2010.275.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"4817_CR40","doi-asserted-by":"publisher","first-page":"030006052312044","DOI":"10.1177\/03000605231204462","volume":"51","author":"P -Zeng","year":"2023","unstructured":"Zeng P, Cai X, Yu X, Huang L, Chen X. HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population. J Int Med Res. 2023;51(10):03000605231204462. https:\/\/doi.org\/10.1177\/03000605231204462.","journal-title":"J Int Med Res"},{"issue":"1","key":"4817_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s43066-021-00154-z","volume":"11","author":"H -Naguib","year":"2021","unstructured":"Naguib H, Kassab H. Potential relation between non-alcoholic fatty liver disease and glycemic and metabolic parameters in subjects without diabetes. Egypt Liver J. 2021;11(1):154. https:\/\/doi.org\/10.1186\/s43066-021-00154-z.","journal-title":"Egypt Liver J"},{"key":"4817_CR42","doi-asserted-by":"publisher","unstructured":"Eckel J. Secretory malfunction. The Cellular Secretome and Organ Crosstalk. 1st ed. Elsevier; 2018. pp. 117\u201354. https:\/\/doi.org\/10.1016\/B978-0-12-809518-8.00005-2.","DOI":"10.1016\/B978-0-12-809518-8.00005-2"},{"issue":"11","key":"4817_CR43","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.36740\/wlek202211121","volume":"75","author":"I -Tverezovska","year":"2022","unstructured":"Tverezovska I, Zhelezniakova N. Selenium-associated mechanisms of progression of nonalcoholic fatty liver disease in hypertensive patients. Wiadomo\u015bci Lekarskie. 2022;75(11):2671\u20136. https:\/\/doi.org\/10.36740\/wlek202211121.","journal-title":"Wiadomo\u015bci Lekarskie"},{"issue":"1","key":"4817_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/20905068.2021.1876288","volume":"57","author":"N -El-Kafrawy","year":"2021","unstructured":"El-Kafrawy N, Atta A, Abdelsattar S, Zewain S. Serum selenoprotein P in lean and obese Egyptian individuals and its relation to insulin resistance. Alex J Med. 2021;57(1):61\u20139. https:\/\/doi.org\/10.1080\/20905068.2021.1876288.","journal-title":"Alex J Med"},{"issue":"1","key":"4817_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1074\/jbc.M113.479386","volume":"289","author":"H -Takayama","year":"2014","unstructured":"Takayama H, Misu H, Iwama H, Chikamoto K, Saito Y, Murao K, et al. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)\/FOXO3a pathway in H4IIEC3 hepatocytes. J Biol Chem. 2014;289(1):335\u201345. https:\/\/doi.org\/10.1074\/jbc.M113.479386.","journal-title":"J Biol Chem"},{"key":"4817_CR46","doi-asserted-by":"publisher","unstructured":"Mita Y, Nakayama K, Inari S, Nishito Y, Yoshioka Y, Sakai N, et al. Selenoprotein p-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models. Nat Commun. 2017;8(1). https:\/\/doi.org\/10.1038\/s41467-017-01863-z.","DOI":"10.1038\/s41467-017-01863-z"},{"issue":"1","key":"4817_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08585-4","volume":"10","author":"Y -Han","year":"2019","unstructured":"Han Y, Hu Z, Cui A, Liu Z, Ma F, Xue Y, et al. Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene. Nat Commun. 2019;10(1):1\u201315. https:\/\/doi.org\/10.1038\/s41467-019-08585-4.","journal-title":"Nat Commun"},{"issue":"2","key":"4817_CR48","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4103\/mmj.mmj_27_21","volume":"35","author":"A -Elkhalaly","year":"2022","unstructured":"Elkhalaly A, El-Deeb G, El-Helbawy N, Elgamal A. Study the level of selenoprotein P in Egyptian patients with nonalcoholic fatty liver. Menoufia Med J. 2022;35(2):510. https:\/\/doi.org\/10.4103\/mmj.mmj_27_21.","journal-title":"Menoufia Med J"},{"issue":"6","key":"4817_CR49","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/oby.21841","volume":"25","author":"R -Giuseppe","year":"2017","unstructured":"Giuseppe R, Koch M, Schlesinger S, Borggrefe J, Both M, M\u00fcller H, et al. Circulating selenoprotein P levels in relation to MRI-derived body fat volumes, liver fat content, and metabolic disorders. Obes (Silver Spring). 2017;25(6):1128\u201335. https:\/\/doi.org\/10.1002\/oby.21841.","journal-title":"Obes (Silver Spring)"},{"issue":"7","key":"4817_CR50","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/antiox11071263","volume":"11","author":"R -Yu","year":"2022","unstructured":"Yu R, Wang Z, Ma M, Xu P, Liu L, Tinkov A, et al. Associations between circulating selenop level and disorders of glucose and lipid metabolism: a meta-analysis. Antioxidants. 2022;11(7):1263. https:\/\/doi.org\/10.3390\/antiox11071263.","journal-title":"Antioxidants"},{"issue":"4","key":"4817_CR51","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N -Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet \u00c9, Baumert T. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4):875. https:\/\/doi.org\/10.3390\/cells9040875.","journal-title":"Cells"},{"issue":"6","key":"4817_CR52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.aohep.2020.07.006","volume":"19","author":"M -Reja","year":"2020","unstructured":"Reja M, Makar M, Visaria A, Marino D, Rustgi V. Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III. Ann Hepatol. 2020;19(6):635\u201340. https:\/\/doi.org\/10.1016\/j.aohep.2020.07.006.","journal-title":"Ann Hepatol"},{"key":"4817_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.17303\/aglp.2025.2.101","volume":"2","author":"M -De Luca","year":"2025","unstructured":"De Luca M. Efficacy of a dietary supplement containing choline, glutathione, selenium, zinc, L. rhamnosus and B. lactis on short-term steatosis and liver function: a pilot study. Adv Gastro Liver Pharmacol. 2025;2:101. https:\/\/doi.org\/10.17303\/aglp.2025.2.101.","journal-title":"Adv Gastro Liver Pharmacol"},{"key":"4817_CR54","doi-asserted-by":"publisher","unstructured":"Zhou L, Liang X, Xie M, Yin J, Huang Y, Li X, et al. A Functional Variant in SEPP1 Interacts With Plasma Selenium Concentrations on 3-Year Lipid Changes: A Prospective Cohort Study. Front Nutr. 2021;8. https:\/\/doi.org\/10.3389\/fnut.2021.789577.","DOI":"10.3389\/fnut.2021.789577"},{"issue":"48","key":"4817_CR55","doi-asserted-by":"publisher","first-page":"40414","DOI":"10.1074\/jbc.m112.421404","volume":"287","author":"K -Hill","year":"2012","unstructured":"Hill K, Wu S, Motley A, Stevenson T, Winfrey V, Capecchi M, et al. Production of Selenoprotein P (Sepp1) by Hepatocytes Is Central to Selenium Homeostasis. J Biol Chem. 2012;287(48):40414\u201324. https:\/\/doi.org\/10.1074\/jbc.m112.421404.","journal-title":"J Biol Chem"},{"key":"4817_CR56","doi-asserted-by":"publisher","unstructured":"Day K, Seale L, Graham R, Cardoso B. Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease. Front Nutr. 2021;8. https:\/\/doi.org\/10.3389\/fnut.2021.744825.","DOI":"10.3389\/fnut.2021.744825"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04817-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:49:31Z","timestamp":1780487371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04817-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4817"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04817-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics statement: Faculty of Medicine Research Ethics Committee at Cairo University approved the study with approval number (MS-298-2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was taken from all contributing authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}